1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Genome-wide CRISPR/Cas9 screen identifies regulators of BCMA expression on multiple myeloma cells
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Deciphering the genetics and mechanisms of predisposition to multiple myeloma
(
- Contribution to journal › Article
- 2023
-
Mark
Functional and molecular profiling of hematopoietic stem cells during regeneration
(
- Contribution to journal › Article
-
Mark
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy : A multicenter Intergroupe Francophone du Myélome study
(
- Contribution to journal › Article
- 2022
-
Mark
Genome-wide association study on 13 167 individuals identifies regulators of blood CD34+cell levels
(
- Contribution to journal › Article
-
Mark
Functional dissection of inherited non-coding variation influencing multiple myeloma risk
(
- Contribution to journal › Article
- 2021
-
Mark
Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing
(
- Contribution to journal › Article
-
Mark
Germline variants at SOHLH2 influence multiple myeloma risk
(
- Contribution to journal › Article
-
Mark
Genome-wide association study on 13,167 individuals identifies regulators of hematopoietic stem and progenitor cell levels in human blood
2021)(
- Working paper/Preprint › Preprint in preprint archive
- 2020
-
Mark
S100A6 is a critical regulator of hematopoietic stem cells.
2020) In Leukemia(
- Contribution to journal › Article